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ABSTRACT
Three collections of Staphylococcus aureus isolates (n = 1058) were investigated to assess the spread of
Panton–Valentine leukocidin (PVL)-producing strains in Greece and their association with skin and soft-
tissue infections (SSTIs). The isolates were collected during 2001–2003 from inpatients and outpatients
with invasive infections in two distinct geographical areas. Clonal types were identiﬁed according to
their ClaI-mecA::ClaI-Tn554::pulsed-ﬁeld gel electrophoresis patterns, and the presence of the lukS-PV
and lukF-PV genes was assessed by PCR. In total, 287 (27%) S. aureus isolates carried the PVL genes: 45%
of methicillin-resistant S. aureus (MRSA) and 12% of methicillin-sensitive S. aureus (MSSA). All the PVL-
positive MRSA isolates belonged to a single clone that was disseminated in the community and
hospitals. The PVL-positive MSSA isolates were polyclonal, with 14 of 65 isolates being associated with
hospital-acquired infections. The community-acquired isolates were from SSTIs, while the hospital-
acquired isolates were associated with surgical wound infections, especially those involving prosthetic
devices. Thus, a unique clone of PVL-positive MRSA has spread in both the community and the hospital
setting in Greece, and has replaced older clonal types.
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INTRODUCTION
Infections caused by community-acquired meth-
icillin-resistant Staphylococcus aureus (CA-MRSA)
have been reported worldwide [1–3]. These newly
described CA-MRSA strains were isolated origin-
ally from patients with skin and soft-tissue
infections (SSTIs), with no apparent risk-factors
for hospital acquisition, and occasionally from
patients with severe necrotising pneumonia [4].
Several features distinguish these strains from
hospital-acquired MRSA (HA-MRSA): they carry
the mecA gene on the type IV staphylococcal
chromosomal cassette mec (SCCmec) element [5];
they are not multidrug-resistant; and they carry
the lukS-PV and lukF-PV genes for Panton–
Valentine leukocidin (PVL), which is a bicompo-
nent cytotoxin virulence factor [6].
Genetic analysis of CA-MRSA by pulsed-ﬁeld
gel electrophoresis (PFGE) and multilocus seq-
uence typing has revealed the presence of different
clonal complexes, suggesting that these strains
have arisen from diverse genetic backgrounds
unrelated to HA-MRSA [1,7]. In a previous study
performed at the University Hospital of Patras in
Greece, 11 PVL-positive MRSA strains were isola-
ted from hospitalised patients during 1998 and
2000; these isolates belonged to aunique clone, type
II::NH::C, and carried SCCmec type IV [8].
The presence of PVL genes has also been
detected, to a lesser extent, among methicillin-
sensitive S. aureus (MSSA) isolates associated
with SSTIs [2,9,10]. Phylogenetic analysis of
PVL-positive MSSA strains has shown that they
belong to different groups, indicating that the
bacteriophage carrying the PVL genes can be
spread easily [10]. The aim of the present study
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was to deﬁne the prevalence and clonal distribu-
tion of PVL-positive MRSA and MSSA among
hospitalised and non-hospitalised patients with
staphylococcal infections in two distinct geo-
graphical regions of the country during a 3-year
period.
MATERIALS AND METHODS
Bacterial isolates and hospitals
Three collections comprising 1058 S. aureus isolates were
studied. These collections originated from three different
hospitals: University Hospital of Patras (UHP) (n = 374; 177
MRSA and 197 MSSA), Karamandaneion Children’s Hospital,
Patras (KHP) (n = 216; 93 MRSA and 123 MSSA), both located
in southwestern Greece, and University Hospital of Larissa
(UHL) (n = 468; 228 MRSA and 240 MSSA), located in central
Greece. These hospitals have 750, 100 and 400 beds, respect-
ively, with c. 219 667 ambulatory visits and 134 000 admis-
sions ⁄ year, and provide healthcare for 1 740 000 inhabitants
(c. 15% of the total population of Greece). All isolates were
from different inpatients and outpatients with S. aureus
infections (one isolate ⁄patient) during the 3-year period
between January 2001 and December 2003.
Isolates obtained within 48 h of hospital admission were
deﬁned as community-acquired, as were isolates from patients
with infection diagnosed in an outpatient department, provi-
ded that there was no history in the past year of hospitalisa-
tion, admission to a nursing home, skilled nursing facility or
hospice, or association with dialysis, surgery, permanent
indwelling catheters or medical devices [11]. Isolates obtained
> 72 h following admission were deﬁned as hospital-acquired.
S. aureus identiﬁcation
Isolates were identiﬁed on the basis of colony morphology,
Gram’s stain, catalase reaction, coagulase tests with rabbit
plasma (bioMe´rieux, Lyon, France) and Slidex Staph Plus
agglutination tests (bioMe´rieux), followed by further identiﬁ-
cation with the API Staph System (bioMe´rieux).
Antimicrobial susceptibility testing
Susceptibility tests were performed by disk-diffusion accord-
ing to NCCLS guidelines [12] for oxacillin, ampicillin, vanco-
mycin, gentamicin, netilmicin, erythromycin, clindamicin,
ciproﬂoxacin, trimethoprim–sulphamethoxazole, linezolid
and fusidic acid (BBL disks; Becton Dickinson, Le Pont de
Claix, France). Oxacillin MICs were determined by the agar
dilution method [13]. All isolates with MICs ‡ 0.5 mg ⁄L were
tested by latex agglutination (bioMe´rieux) for the production
of PBP2a protein, and by PCR for the presence of the mecA
gene (see below). b-Lactamase production was tested with
nitroceﬁn disks (BBL, Becton Dickinson) according to the
instructions of the manufacturer.
PCR procedures
The mecA and PVL genes (lukS-PV and lukF-PV) were detected
by PCR as described previously [14,15]. PCR products were
analysed by electrophoresis on agarose 1% w ⁄v gels. S. aureus
ATCC 49775 was used as a positive control for the PVL genes.
Molecular typing
DNA extraction and Southern blot hybridisation of ClaI digests
withmecA- and Tn554-speciﬁc DNA probes, as well as PFGE of
SmaI digests of chromosomal DNA, were performed as des-
cribed previously [16] in a CHEF DR III apparatus (Bio-Rad
Laboratories, Richmond, CA, USA). Visual interpretation of the
PFGE banding patterns and the assignment of types were as
suggested by Tenover et al. [17]. Clones were deﬁned according
to their ClaI-mecA::ClaI-Tn554::PFGE patterns, and were com-
pared to clonal types identiﬁed previously in UHP [8].
RESULTS
Prevalence of Panton–Valentine leukocidin
production among the S. aureus isolates tested
In total, 287 (27%) of 1058 S. aureus isolates were
positive for the PVL genes by PCR, although there
was wide variation between the frequencies for
MRSA and MSSA (Tables 1 and 2). In the MRSA
group, 222 (45%) isolates were PVL-positive, of
which most (n = 157) were isolates from commu-
nity-acquired SSTIs. Among the CA-MRSA
isolates, 60% were associated with furunculosis,
28% with cutaneous abscesses, and 12% with
cellulitis. At UHP, 64 PVL-positive MRSA strains
were isolated from hospital-acquired surgical
wound infections, mainly involving prosthetic
devices, among patients who had undergone
surgery at the Departments of Surgery and
Table 1. Community-acquired (CA) and hospital-acquired (HA) methicillin-resistant Staphylococcus aureus isolates from
the participating hospitals during the 3-year period (n = 498)
CA (n = 218) HA (n = 280)
Total
2001 (%) 2002 (%) 2003 (%) 2001 (%) 2002 (%) 2003 (%)
UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL
PVL(+)a 6 (85) 3 (37.5) – 11 (73) 10 (34.5) 22 (79) 21 (91) 35 (71) 49 (89) 10 (24) – – 25 (54) 1 (25) – 29 (64) – – 222 (45)
PVL(–) 1 (15) 5 (62.5) 4 (100) 4 (27) 19 (65.5) 6 (21) 2 (9) 14 (29) 6 (11) 31 (76) 1 (100) 31 (100) 21 (46) 3 (75) 66 (100) 16 (36) 2 (100) 44 (100) 276 (55)
Total 7 8 4 15 29 28 23 49 55 41 1 31 46 4 66 45 2 44 498
UHP, University Hospital of Patras; KHP, Karamandaneion Hospital of Patras; UHL, University Hospital of Larissa.
aBased on PCR results for the lukS-PV and lukF-PV genes.
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Orthopaedics during the 3-year period. One
hospital-acquired PVL-positive MRSA isolate
was obtained at KHP from a patient with bacter-
aemia. No HA-MRSA strains were identiﬁed at
UHL. The rates of MRSA infections in the parti-
cipating hospitals during 2001, 2002 and 2003
were: UHP, 23%, 28% and 28%; KHP, 13.6%,
33% and 35%; and UHL, 15%, 28% and 41%,
respectively. The incidence of PVL-positive
MRSA increased during the study period in all
three hospitals (Table 1). Fig. 1 shows the per-
centage of PVL-positive CA- and HA-MRSA
isolates during the 3-year period.
In comparison with MRSA, the MSSA isolates
included a signiﬁcantly lower proportion (12%)
of PVL producers. The rates of CA-MSSA infec-
tion in the participating hospitals during 2001,
2002 and 2003 were: UHP, 11%, 25% and 35%;
KHP, 5%, 14% and 23%; and UHL, 0%, 18.5%
and 35%, respectively. HA-MSSA strains were
isolated only in UHP from patients with surgical
wound infections (Table 2).
Molecular typing and antibiotic resistance
phenotypes
On the basis of ClaI-mecA::ClaI-Tn554::PFGE pat-
terns, the MRSA isolates were grouped into six
clonal types (Table 3). All the PVL-positive iso-
lates belonged to clone II::NH::C, and vice versa,
except for one of the 30 HA-MRSA isolates,
obtained in 2003 from a patient hospitalised in
the Urology Department at UHP, which belonged
to clone II::NH::C and did not carry the PVL genes.
Most (195 ⁄ 222; 88%) of the PVL-positive MRSA
isolates were resistant to b-lactams and fusidic
acid, while the remaining 27 MRSA isolates were
resistant only to b-lactams. The oxacillin MICs for
all the MRSA isolates belonging to clone II::NH::C
were relatively low (0.5–24 mg ⁄L).
Multiresistant, PVL-negative MRSA isolates
belonged to clonal types X¢::KK::B, III¢::KK::B
and III::KK::B, obtained from hospital-acquired
infections, at UHP and UHL (Table 3). Clone
VII¢::NH::A comprised PVL-negative isolates
resistant to b-lactams only, which were distri-
buted in all participating hospitals and were
associated with community- and hospital-
acquired infections, while three more MRSA
isolates obtained during 2002 at UHP belonged
to a new clone (II::NH::F).
The MSSA isolates belonged to 32 PFGE types,
with the PVL-positive isolates belonging to nine
types, mainly types M, I and Y. Ten PVL-positive
isolates belonged to pulsotypes A (six isolates)
and C (four isolates), which were related to MRSA
clonal types A and C. Among the PVL-positive
MSSA isolates, 15 of 65 were resistant to fusidic
Table 2. Community-acquired (CA) and hospital-acquired (HA) methicillin-susceptible Staphylococcus aureus isolates from
the participating hospitals during the 3-year period (n = 560)
CA (n = 257) HA (n = 303)
Total
2001 (%) 2002 (%) 2003 (%) 2001 (%) 2002 (%) 2003 (%)
UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL UHP KHP UHL
PVL(+)a 2 (11) 1 (5) – 6 (25) 5 (14) 5 (18.5) 11 (35) 9 (23) 12 (35) 1 (3) – – 4 (11) – – 9 (17) – – 65 (12)
PVL(–) 16 (89) 18 (95) 31 (100) 18 (75) 30 (86) 22 (81.5) 20 (65) 29 (77) 22 (65) 31 (97) 12 (100) 43 (100) 34 (89) 9 (100) 49 (100) 45 (83) 10 (100) 56 (100) 495 (88)
Total 18 19 31 24 35 27 31 38 34 32 12 43 38 9 49 54 10 56 560
UHP, University Hospital of Patras; KHP, Karamandaneion Hospital of Patras; UHL, University Hospital of Larissa.
aBased on PCR results for the lukS-PV and lukF-PV genes.
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Fig. 1. Percentage of community-acquired (CA) and hos-
pital-acquired (HA) PVL-positive methicillin-resistant Sta-
phylococcus aureus (MRSA) isolates among the total MRSA
isolates in the participating hospitals during each year.
UHP, University Hospital of Patras; KHP, Karamandane-
ion Hospital of Patras; UHL, University Hospital of
Larissa.
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acid. b-Lactamase production was detected in
90% of the MRSA isolates and in 60% of the
MSSA isolates.
DISCUSSION
A signiﬁcant increase in PVL-positive isolates of
S. aureuswas observed inGreece during 2001–2003,
most of which were MRSA (222 ⁄ 287; 77%). Of the
CA-MRSA isolates, 72% (157 ⁄ 218) carried the PVL
genes, while 23% (65 ⁄ 280) of HA-MRSA isolates
were also PVL-positive. In contrast, only 20% of
MSSA isolates from outpatients and 5% of isolates
from inpatients carried the PVL genes. The PVL-
positive S. aureus isolates fromoutpatientswere the
primary causative agents of skin infections.
Intra-family spread was detected, with three
members infected in each of four families of low
socio-economic status. Nosocomial isolates were
recovered from surgical wound infections, especi-
ally when prosthetic devices were present. One
isolate was from a case of bacteraemia in a child
withno apparentprimary staphylococcal infection.
PVL-positive S. aureus isolates have been associ-
ated only rarely with secondary skin infections or
bacteraemia [9], although PVL-positive MRSA
isolates have been described as the causative
agents of musculoskeletal infections among chil-
dren with an increased likelihood of complications
[18].
The ﬁrst PVL-positive HA-MRSA isolate in
Greece was obtained in UHP from a catheter
culture of a premature baby in 1998, suggesting
that the strain had been acquired from a health-
care worker [8]. During 2000, another ten PVL-
positive HA-MRSA isolates were obtained from
patients with underlying diseases [8], and it is
clear that there has been an increase in the
incidence of CA-MRSA and HA-MRSA infections
caused by PVL-positive strains. A parallel in-
crease was also observed in the overall percentage
of total MRSA isolates during the same period,
probably caused by the spread of PVL-positive
strains. It has been reported that CA-MRSA
strains have a faster growth rate than HA-MRSA
strains, resulting in successful colonisation [7].
This ﬁnding, combined with their enhanced viru-
lence, may explain the increasing rate of infections
caused by PVL-positive S. aureus. The low-level
oxacillin resistance (MIC 0.5–24 mg ⁄L) of these
strains [7] means that they may be misclassiﬁed as
oxacillin-sensitive by conventional methods, with
the consequence that therapeutic use of b-lactams
might contribute to their propagation in the com-
munity. In the present study, most MRSA and, to a
lesser extent, MSSA isolates were also resistant to
fusidic acid. This phenotype was observed in
Germany and France among PVL-positive CA-
MRSA isolates [3,19]. However, Diep et al. [2]
reported a multiresistant clone of PVL-positive
MRSA, raising the concern that these strains may
become disseminated in hospitals.
PFGE analysis of the PVL-positive S. aureus
isolates in the present study revealed the spread
of a single clone (II::NH::C) among MRSA in the
community and in the geographically distinct
participating hospitals. Strains belonging to this
clone have been characterised previously as
SCCmec type IV variant and sequence type ST80
[8]. PVL-positive MRSA isolates belonging to
ST80 have been detected in several countries
[3,20]. Other studies have demonstrated the pres-
ence of different clones of PVL-positive strains,
indicating the independent origins of these clonal
groups [2,7,9], and it has been reported that PVL,
in combination with the SCCmec type IV element,
Table 3. Clonal types of methicillin-resistant Staphylococcus aureus (ClaI-mecA::ClaI-Tn554::PFGE patterns) associated with
community-acquired (CA) and hospital-acquired (HA) infections
Clonal types
2001 2002 2003
Total
UHP
(n = 48)
KHP
(n = 9)
UHL
(n = 35)
UHP
(n = 61)
KHP
(n = 33)
UHL
(n = 94)
UHP
(n = 68)
KHP
(n = 51)
UHL
(n = 99)
CA HA CA HA CA HA CA HA CA HA CA HA CA HA CA HA CA HA
II::NHa::C 6 10 3 – – – 11 25 10 1 22 – 21 30 35 – 49 – 223 (45%)
X¢::KK::B – 19 – – – 18 – 11 – – – 47 – 12 – – – 34 141 (28%)
VII¢::NH::A 1 10 5 1 4 10 4 4 19 3 6 12 2 2 14 2 6 7 112 (22.5%)
III¢::KK::B – 2 – – – 3 – – – – – 4 – 1 – – – 2 12 (2.5%)
III::KK::B – – – – – – – 3 – – – 3 – – – – – 1 7 (1.5%)
II::NH::F – – – – – – – 3 – – – – – – – – – – 3 (0.5%)
Total 7 41 8 1 4 31 15 46 29 4 28 66 23 45 49 2 55 44 498 (100%)
UHP, University Hospital of Patras; KHP, Karamandaneion Hospital of Patras; UHL, University Hospital of Larissa.
aNH, no homology with Tn554.
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contributes to the spread of MRSA in the com-
munity [1,3,7,20,21]. All the PVL-positive MRSA
isolates in the present study belonged to the same
clone, and their frequency increased to represent
most of the MRSA isolates obtained during 2003.
The antibiotic resistance phenotype of these iso-
lates (resistant only to b-lactams and not to fusidic
acid) was the same as that of PVL-negative MRSA
isolates belonging to clone VII¢::NH::A.
The frequency of PVL production among SSTI-
associated MSSA isolates in this study was 12%.
Diep et al. [2] identiﬁed only 6.7% MSSA isolates
as PVL-positive, while Johnsson et al. [9] reported
that only one of 48 MSSA isolates carried the PVL
genes. The MSSA isolates in the present study
belonged to 32 pulsotypes, with the PVL-positive
isolates belonging to nine pulsotypes. Other
studies of PVL-positive MSSA isolates have also
detected polyclonality, providing evidence for the
horizontal transfer of the PVL-bearing prophages
[2,4,9,10]. The identiﬁcation of PVL-positive
MSSA isolates that were related genetically to
the MRSA pulsotypes (PFGE types A and C)
raises the question as to whether the CA-MRSA
isolates emerged through acquisition of PVL
genes by an MRSA strain, or through acquisition
of the mecA gene by a VL-positive MSSA strain.
In conclusion, this study provides evidence that
PVL-positive S. aureus strains can be isolated from
community-acquired infections, and that theyhave
also disseminated in the hospital setting. InGreece,
one particular clone of PVL-positive MRSA has
become predominant among MRSA isolates and
has replaced older clonal types. The presence of the
PVL genes cannot be predicted on the basis of the
susceptibility phenotype of isolates; thus amolecu-
lar method should be used to investigate isolates
recovered from patients with SSTIs.
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